Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patients.

D. Olmos; J. Ern Ang; [No Value] et al; E.E. Voest; S. Kaye

Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patients.

Translated title of the contribution: Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patients.

D. Olmos, J. Ern Ang, [No Value] et al, E.E. Voest, S. Kaye

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patients.
Original language	Undefined/Unknown
Pages (from-to)	594-596
Number of pages	3
Journal	European Journal of Cancer
Volume	48
Issue number	4
Publication status	Published - 2012

Cite this

@article{e8e9553c05174e72b7867245a8e0bf99,

title = "Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patients.",

author = "D. Olmos and {Ern Ang}, J. and {et al}, {[No Value]} and E.E. Voest and S. Kaye",

year = "2012",

language = "Undefined/Unknown",

volume = "48",

pages = "594--596",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "4",

}

Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patients. / Olmos, D.; Ern Ang, J.; et al, [No Value] et al.
In: European Journal of Cancer, Vol. 48, No. 4, 2012, p. 594-596.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patients.

AU - Olmos, D.

AU - Ern Ang, J.

AU - et al, [No Value]

AU - Voest, E.E.

AU - Kaye, S.

PY - 2012

Y1 - 2012

M3 - Article

SN - 0959-8049

VL - 48

SP - 594

EP - 596

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 4

ER -